The C242T polymorphism of the gene encoding cytochrome b-245 alpha is not associated with paediatric ischaemic stroke: Family-based and case-control study

Neurologia i Neurochirurgia Polska

Volumn 44, Issue 5, 2010, Pages 453-458

  Niemiec, Paweł ^a   Zak, Iwona ^a   Emich Widera, Ewa ^a   Balcerzyk, Anna ^a   Kopyta, Ilona ^a   Nowak, Tomasz ^a   Wendorff, Jerzy ^b   Pałatyńska, Katarzyna ^b   Kaciński, Marek ^c   Pienczk Rȩcławowicz, Karolina ^d   Pilarska, Ewa ^d  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

CYBA gene; Free radicals; Ischaemic stroke; NAD(P)H oxidases; Paediatric stroke; Polymorphism

Indexed keywords

CYTOCHROME B; CYTOCHROME B245 ALPHA; CYTOSINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THYMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELISM; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; LIGHT CHAIN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 78149347683     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60135-3     Document Type: Article

References (24)

1. Pavlakis S.G., Kingsley P.B., Bialer M.G. Stroke in children: genetic and metabolic issues J Child Neurol 2000; 15: 308-315.
2. Kirkham F., Sébire G., Steinlin M., et al. Arterial ischaemic stroke in children. Review of the literature and strategies for future stroke studies. Thromb Haemost 2004; 92: 697-706. (Pubitemid 39386693)
3. Jȩdrzejewska J., Członkowska A., Kobayashi A. Pomostowanie aortalno-wieńcowe u osób z objawowym lub bezobjawowym zwȩżeniem tȩtnicy szyjnej wewnȩtrznej [Article in Polish]. Neurol Neurochir Pol 2009; 43: 263-271.
4. Kopyta I., Marszal E. Czynniki ryzyka udaru mózgu u dzieci [Article in Polish]. Udar Mozgu 2004; 6: 47-55.
5. Balcerzyk A., Zak I., Niemiec P., et al. APOE gene e polymorphism does not determine predisposition to ischemic stroke in children. Pediatr Neurol 2010; 43: 25-28.
6. Miller A.A., Drummond G.R, Sobey C.G. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther 2006; 111: 928-948.
7. Miller A.A., Drummond G.R., Sobey C.G. Reactive oxygen species in the cerebral circulation: are they all bad? Antioxid Redox Signal 2006; 8: 1113-1120.
8. Niemiec P., Zak I. Naczyniowe oksydazy NAD(P)H - znaczenie w patogenezie miażdżycy [Article in Polish]. Postepy Bio chem 2005; 51: 1-11.
9. Lassegue B., Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-R297.
10. Guzik T.J., West N.E., Black E., et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000; 86: E85-E90.
11. Herkert O., Diebold I., Brandes R.P., et al. NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells. Circulation 2002; 105: 2030-2036. (Pubitemid 34465264)
12. Krötz F., Sohn H.Y., Gloe T. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 2002; 100: 917-924. (Pubitemid 34832618)
13. Alexandrova M., Bochev P., Markova V., et al. Dynamics of free radical processes in acute ischemic stroke: influence on neurological status and outcome. J Clin Neurosci 2004; 11: 501-506. (Pubitemid 38869480)
14. Miller A.A., Drummond G.R., Schmidt H.H., et al. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res 2005; 97: 1055-1062.
15. Dinauer M.C., Pierce E.A., Bruns G.A., et al. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 1990; 86: 1729-1737.
16. Pittock S.J., Meldrum D., Hardiman O., et al. The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis 2003; 12: 1-7. (Pubitemid 36292851)
17. Niemiec P., Zak I., Wita K. The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia. Coron Artery Dis 2007; 18: 339-346. (Pubitemid 47186833)
18. Wyche K.E., Wang S.S., Griendling K.K., et al. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004; 43: 1246-1251.
19. Shimo-Nakanishi Y., Hasebe T., Suzuki A., et al. Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 2004; 175: 109-115. (Pubitemid 38746917)
20. Macías-Reyes A., Rodríguez-Esparragón F., Caballero-Hidalgo A., et al. Insight into the role of CYBA A640G and C242T gene variants and coronary heart disease risk. A case-control study. Free Radic Res 2008; 42: 82-92. (Pubitemid 351372194)
21. Nakano T., Matsunaga S., Nagata A., et al. NAD(P)H oxidase p22phox Gene C242T polymorphism and lipoprotein oxidation. Clin Chim Acta 2003; 335:101-107.
22. Ito D., Murata M., Watanabe K., et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000; 31: 936-939. (Pubitemid 30198442)
23. Kuroda J., Kitazono T., Ago T., et al. NAD(P)H oxidase p22phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama study. Eur J Neurol 2007; 14: 1091-1097. (Pubitemid 47459733)
24. Genius J., Grau A.J., Lichy C. The C242T polymorphism of the NAD(P)H oxidase p22phox subunit is associated with an enhanced risk for cerebrovascular disease at a young age. Cerebrovasc Dis 2008; 26: 430-433.